Multimedia Release

How an Epigenetic 'Lock' Drives a Rare Disease (1 of 1)

Reports and Proceedings

American Association for the Advancement of Science (AAAS)

How an Epigenetic 'Lock' Drives a Rare Disease (1 of 1)

image: Culturing skin biopsies from systemic sclerosis patients with the drug JQ1 for 10 days cleared collagen in the samples. This material relates to a paper that appeared in the June 19, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by J.Y. Shin at Johns Hopkins University School of Medicine in Baltimore, MD; and colleagues was titled, 'Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis.' view more 

Credit: J.Y. Shin <i>et al., Science Translational Medicine</i> (2019)


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.